MCCQE Exam Dumps - Medical Council of Canada Qualifying Examination Part 1 Exam

This is a classic presentation of diabetic peripheral neuropathy: bilateral distal sensory symptoms with preserved motor function and no other systemic findings. The most useful test to confirm this in a previously undiagnosed patient is HbA1c.

Toronto Notes 2023 – Endocrinology, Diabetes Complications:

“Peripheral neuropathy is a common complication of undiagnosed or poorly controlled diabetes. Confirm with HbA1c if diagnosis is not yet established.”

MCCQE1 Objectives – Internal Medicine > Endocrinology:

“Candidates should evaluate for diabetes in patients with peripheral neuropathy and screen appropriately with HbA1c.”

Folate (B) and B12 deficiency may also cause neuropathy but are less likely in the absence of nutritional risk factors. Other choices (A, D, E) are unrelated to this pattern.

====================================================

This patient’s obstetric history suggests recurrent fetal macrosomia (birthweight > 4000–4500 g) and rapid (precipitous) labours. MCCQE objectives emphasize identifying maternal risk factors for postpartum hemorrhage (PPH) , particularly those associated with uterine atony , the most common cause of PPH. Delivery of a macrosomic infant increases uterine overdistension, which reduces effective postpartum uterine contraction and predisposes to atony and hemorrhage. In addition, precipitous labour can be associated with genital tract trauma, which can also contribute to postpartum bleeding, but the strongest and most consistent risk factor in the options provided is PPH from atony related to prior large infants.

The other choices are less supported by the stem: prior macrosomic term deliveries do not inherently increase risk of preterm delivery, gestational hypertension, or DVT. Therefore, the most likely risk to anticipate and plan for is postpartum hemorrhage, prompting proactive intrapartum planning (active management of the third stage, readiness with uterotonics, and risk-based monitoring).

Given the request for opioids and history of non-prescribed opioid use (oxycodone obtained from a friend), the next appropriate step is to conduct a urine drug screen. This helps assess current substance use and guides safe prescribing decisions.

Toronto Notes 2023 – Pain Management and Addiction Medicine:

“Urine drug screening is recommended before initiating opioid therapy or when there is suspicion of substance misuse. A history of using non-prescribed opioids mandates assessment for opioid use disorder and further risk stratification.”

MCCQE1 Objectives – Internal Medicine > Chronic Pain:

“Candidates must assess for opioid misuse and dependence before initiating opioid therapy. Urine drug testing is a standard tool in this assessment.”

Providing naloxone (A) may be appropriate later if opioids are prescribed, but the priority is evaluation. Cannabis (B) is not first-line and lacks controlled evidence in chronic pain. Tramadol (D) is an opioid-like agent and not appropriate until misuse risk is evaluated.

The patient presents with an acutely inflamed joint and fever, raising concern for septic arthritis. A history of gout does not exclude infection. The first and most urgent step in any monoarthritis with systemic signs (fever) is joint aspiration to assess for crystals, white cells, and organisms.

Toronto Notes 2023 – Rheumatology, “Monoarthritis”:

“Always rule out septic arthritis in a hot, swollen joint, especially when fever is present. Joint aspiration is essential to differentiate infection from crystal arthropathy.”

MCCQE1 Objectives (Medicine > Rheumatology > 49-1):

“Candidates must identify red flags for septic arthritis and understand that arthrocentesis is the first step in diagnosis and management.”

Initiating NSAIDs or acetaminophen without diagnosis (C, D) can delay appropriate care. Radiographs (B) do not help differentiate gout from infection acutely. Blood cultures (E) may help, but aspiration is more diagnostic.

====================================================

Comprehensive and Detailed Explanation:

Providing clinical advice (particularly treatment advice) without formally seeing or evaluating the patient creates a physician-patient relationship, potentially establishing a duty of care. If the advice leads to harm, you could be found liable, even if you never saw the patient directly.

Toronto Notes 2023 – Legal Medicine:

“Giving specific medical advice about diagnosis or treatment may imply a physician-patient relationship and establish duty of care.”

MCCQE1 Objectives (ELOM > 90-2: Legal Risk Management):

“Candidates must understand that liability can arise from informal consultations where medical advice is given.”

Providing advice (D) is riskier than simply hearing about a case or patient (A, C). Recommending consultation (B) does not establish duty of care. Not seeing the patient (E) does not automatically shield from liability if treatment advice was given.

—

Comprehensive and Detailed Explanation:

Hyponatremia in a patient with lung cancer and euvolemia strongly suggests syndrome of inappropriate antidiuretic hormone secretion (SIADH), especially from small cell carcinoma. Serum osmolality is the best initial test to confirm hypotonic hyponatremia and distinguish true hyponatremia from pseudohyponatremia or other causes.

Toronto Notes 2023 – Endocrinology, “Hyponatremia”:

“Serum osmolality helps classify hyponatremia as hypotonic, isotonic, or hypertonic. SIADH typically causes hypotonic hyponatremia in euvolemic patients.”

MCCQE1 Objectives (Endocrinology > 37-1: Electrolyte Disorders):

“Candidates must evaluate the type and cause of hyponatremia using clinical status and laboratory tests including serum osmolality.”

Urine sodium (B) is useful after confirming hypotonicity. PTHrP (E) is associated with hypercalcemia of malignancy, not hyponatremia. Urinalysis (A) and CrCl (D) are less directly informative.

Spironolactone is a potassium-sparing diuretic that can cause hyperkalemia, especially in patients with impaired renal function. Hyperkalemia can lead to life-threatening arrhythmias, particularly wide complex tachycardia or ventricular fibrillation.

Toronto Notes 2023 – Cardiology and Nephrology, “Hyperkalemia” Section:

“Patients with CKD are at increased risk for hyperkalemia, particularly when taking potassium-sparing medications such as spironolactone. Severe hyperkalemia may cause bradycardia or wide-complex tachyarrhythmias.”

MCCQE1 Objectives (Internal Medicine > 76-2: Electrolyte Abnormalities):

“Candidates must recognize drug-induced hyperkalemia as a cause of cardiac arrhythmias, especially in patients with renal dysfunction.”

Hydrochlorothiazide (B) can cause hypokalemia. Metoprolol (C) and diltiazem (E) are rate-controlling agents but do not typically cause wide complex tachycardia. Clopidogrel (D) has no effect on cardiac conduction.

====================================================

This patient is experiencing mild hypothermia (32–35°C), evidenced by shivering, ataxia, and tachycardia. First-line management includes passive external rewarming — removing wet clothing, providing warm blankets, and ensuring a warm environment (ambient temperature ~28°C).

Toronto Notes 2023 – Emergency Medicine, Environmental Injuries:

“Mild hypothermia (32–35°C): Treatment includes passive rewarming (warm blankets, warm environment). Avoid active rewarming methods to extremities due to risk of afterdrop.”

MCCQE1 Objectives – Internal Medicine > Environmental Exposure:

“Candidates must recognize appropriate levels of hypothermia and select evidence-based rewarming strategies based on severity.”

Options A, C, and D are used in moderate to severe hypothermia ( < 32°C or unconscious patients). Heating pads (B) may cause tissue damage, especially with frostbite.

====================================================